Stock 4583 CHIOME BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Chiome Bioscience Inc.

Equities

4583

JP3205350006

Biotechnology & Medical Research

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
123 JPY 0.00% Intraday chart for Chiome Bioscience Inc. -3.15% -8.89%
Apr. 01 Chiome Bioscience Cancels License Agreements with ADC Therapeutics MT
Feb. 13 Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited CI

Business Summary

Chiome Bioscience Inc. is a company mainly engaged in the research and development of antibody drugs, and the provision of development support services. The Company operates in two business segments. The Drug Discovery segment is engaged in the research and development of specific antibodies based on new antigens and mechanisms and licensing to pharmaceutical companies. The Drug Discovery Support segment is engaged in development of lead antibodies for therapeutic drugs in collaborating with pharmaceutical companies in Japan and overseas.

Number of employees: 53

Sales per Business

JPY in Million2022Weight2023Weight Delta
Drug Discovery Support
100.0 %
631 100.0 % 682 100.0 % +8.19%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
96.6 %
597 94.7 % 659 96.6 % +10.40%
Singapore
2.8 %
25 4.0 % 19 2.8 % -24.17%
Europe
0.6 %
8 1.3 % 4 0.6 % -52.09%

Managers

Managers TitleAgeSince
Shigeru Kobayashi PSD
 President 70 09-03-31
Arihiko Bijohira BRD
 Director/Board Member 45 12-12-31

Members of the board

Members of the board TitleAgeSince
Akiyuki Furuya BRD
 Director/Board Member 79 17-02-28
Haruhisa Kubota BRD
 Director/Board Member 74 19-03-27
Shigeru Kobayashi PSD
 President 70 09-03-31
Arihiko Bijohira BRD
 Director/Board Member 45 12-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 55,720,600 50,222,151 ( 90.13 %) 6,149 ( 0.0110 %) 90.13 %

Shareholders

NameEquities%Valuation
Kunihiro Ohta
1.738 %
962,700 1.738 % 909 617 ¥
Growth Capital KK
1.697 %
940,000 1.697 % 888 168 ¥
Kenji Watanabe
1.047 %
580,000 1.047 % 548 019 ¥
Koji Yoshimura
0.9025 %
500,000 0.9025 % 472 430 ¥
Tetsuo Iisaku
0.8971 %
497,000 0.8971 % 469 595 ¥
Fukutaro Yamato
0.6498 %
360,000 0.6498 % 340 150 ¥
Shigekazu Hirata
0.5103 %
282,700 0.5103 % 267 112 ¥
Shigeru Kobayashi
0.3855 %
213,600 0.3855 % 201 822 ¥
Chiome Bioscience Restricted Stock Compensation Plan
0.3038 %
168,300 0.3038 % 159 020 ¥
Goldman Sachs Asset Management International
0.0505 %
28,000 0.0505 % 26 456 ¥

Holdings

NameEquities%Valuation
CHIOME BIOSCIENCE INC.
0.00%
 100 0.00% 94 $

Company contact information

Chiome Bioscience, Inc.

Sumitomo Fudosan Nishi-Shinjuku Bldg 3-12-1 Hon-machi

151-0071, Tokyo

+

http://www.chiome.co.jp
address Chiome Bioscience Inc.(4583)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CHIOME BIOSCIENCE INC. Stock Chiome Bioscience Inc.
-8.89% 44.06M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+2.05% 42.59B
MODERNA, INC. Stock Moderna, Inc.
+7.75% 40.65B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 40.57B
CELLTRION, INC. Stock Celltrion, Inc.
-11.96% 26.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.81% 24.81B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.35% 18.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.24% 12.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.13% 11.7B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.95% 11.1B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 4583 Stock
  4. Company Chiome Bioscience Inc.